Sign up for free and continue reading this report
SAVA
Cassava Sciences
Last Price
$3.49
Last updated:
Market Cap
$1.38b
7D Change
-18.74%
1 Year Change
-84.24%
Company Overview
Industries
- Manufacturing
- Pharmaceutical Products
- Pharmaceutical Preparations
Exchange
NASDAQ
Next Earnings Date
Nov. 11, 2024
Cassava Sciences, Inc. is a clinical-stage biotechnology company focused on developing new therapeutics for neurodegenerative diseases, particularly Alzheimer's disease. Their lead therapeutic candidate is simufilam, an investigational drug designed to treat Alzheimer's disease. The company is currently conducting Phase 3 clinical trials of simufilam.
Use of Interest
Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|
Company Impact
Help us evaluate Cassava Sciences's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.
Justification for our Halal Rating
Recent News & Updates
- Nov. 26
- Nov. 26
- Nov. 26
- Nov. 25
- Nov. 25
- Nov. 25
- Nov. 25
- Nov. 25
- Nov. 25
- Nov. 25
- Nov. 25
- Nov. 24
- Nov. 18
- Nov. 12
- Nov. 07
- Oct. 31
- Oct. 30
- Oct. 28
- Oct. 17
- Oct. 09
- Oct. 09
- Oct. 08
- Oct. 08
- Sep. 30
- Sep. 30
- Sep. 26
- Sep. 26
- Sep. 26
- Sep. 25
- Sep. 24
- Sep. 09
- Sep. 03
- Aug. 19
- Aug. 08
- Aug. 08
- Aug. 08
- Aug. 08
- Aug. 06
- Aug. 06
- Aug. 06
- Aug. 06
- Aug. 05
- Aug. 05
- Aug. 02
- Jul. 31
- Jul. 30
- Jul. 30
- Jul. 30
- Jul. 30
- Jul. 30
- Jul. 30
- Jul. 28
- Jul. 24
- Jul. 23
- Jul. 22
- Jul. 22
- Jul. 22
- Jul. 22
- Jul. 22
- Jul. 22
- Jul. 22
- Jul. 22
- Jul. 18
- Jul. 17
- Jul. 17
- Jul. 17
- Jul. 17
- Jul. 17
- Jul. 09
- Jul. 08
- Jul. 08
- Jul. 05
- Jul. 02
- Jul. 01
- Jul. 01
- Jul. 01
- Jul. 01
- Jul. 01
- Jul. 01
- Jun. 28
- Jun. 28
- Jun. 28
- Jun. 28
- Jun. 27
- Jun. 26
- Jun. 26
- Jun. 04
- May. 17
- May. 17
- May. 10
- May. 10
- May. 10
- May. 09
- May. 08
- May. 08
- Apr. 30
- Apr. 15
- Apr. 05
- Mar. 25
- Mar. 24
- Mar. 23
- Mar. 17
- Mar. 11
- Mar. 11
- Mar. 04
- Mar. 04
- Feb. 28
- Feb. 28
- Feb. 28
- Feb. 21
- Feb. 16
- Feb. 10
- Feb. 09
- Feb. 09
- Feb. 08
- Feb. 08
- Feb. 08
- Feb. 08
- Feb. 08
- Feb. 08
- Feb. 08
- Feb. 08
- Feb. 07
- Feb. 05
- Feb. 03
- Jan. 25
- Jan. 16
- Jan. 05
- Jan. 05
- Jan. 05
- Dec. 21
- Dec. 19
- Dec. 15
- Dec. 13
- Dec. 12
- Dec. 08
- Dec. 06
- Nov. 20
- Nov. 16
- Nov. 07
- Nov. 07
- Nov. 07
- Nov. 07
- Nov. 06
- Oct. 30
- Oct. 27
- Oct. 25
- Oct. 19
- Oct. 17
- Oct. 16
- Oct. 13
- Oct. 13
- Oct. 13
- Oct. 13
- Oct. 13
- Oct. 13
- Oct. 13
- Oct. 13
- Oct. 13
- Oct. 13
- Oct. 12
- Oct. 11
- Oct. 06
- Oct. 02
- Sep. 18
- Sep. 14
- Sep. 11
- Sep. 11
- Aug. 29
- Aug. 25
- Aug. 25
- Aug. 25
- Aug. 24
- Aug. 24
- Aug. 24
- Aug. 24
- Aug. 24
- Aug. 10
- Aug. 03
- Aug. 03
- Aug. 03
- Aug. 03
- Aug. 03
- Jul. 13
- Jul. 09
- Jul. 07
- Jul. 05
- Jul. 05
- Jul. 05
- Jul. 05
- Jul. 05
- Jul. 05
- Jul. 05
- Jun. 27
- Jun. 20
- Jun. 12
- May. 26
- May. 23
- May. 23
- May. 16
- May. 12
- May. 11
- May. 09
- May. 09
- May. 01
- May. 01
- May. 01
- May. 01
- Apr. 26
- Apr. 06
- Mar. 10
- Mar. 09
- Mar. 09
- Mar. 09
- Mar. 09
- Mar. 09
- Mar. 09
- Mar. 09
- Mar. 08
- Mar. 08
- Mar. 08
- Mar. 08
- Mar. 05
- Feb. 28
- Feb. 28
- Feb. 21
- Feb. 13
- Feb. 08
- Feb. 01
- Jan. 30
- Jan. 27
- Jan. 26
- Jan. 25
- Jan. 24
- Jan. 24
- Jan. 24
- Jan. 24
- Jan. 24
- Jan. 24
- Jan. 24
- Jan. 19
- Jan. 18
- Jan. 18
- Jan. 11
- Jan. 07
- Dec. 28
- Dec. 22
- Dec. 22
- Dec. 20
- Dec. 15
- Dec. 14
- Dec. 13
- Dec. 12